This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: University of California, Valorbec S.e.c.. Active years: 2019.
Company Filing History:
1 out of 15,988 
1 out of 4 Years Active: 2019
Title: Lauren Narcross: Innovator in Tyrosine Hydroxylase Variants
Introduction
Lauren Narcross is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of tyrosine hydroxylase variants. Her work focuses on enhancing the production of L-DOPA, a crucial compound in the treatment of various neurological disorders.
Latest Patents
Lauren Narcross holds a patent for "Tyrosine hydroxylase variants and methods of use thereof." This patent describes a variant tyrosine hydroxylase that increases the production of L-DOPA in host cells expressing the enzyme. The patent also includes nucleic acids encoding the variant tyrosine hydroxylase and genetically modified host cells. Additionally, it outlines methods for producing L-DOPA, detecting L-DOPA levels in cells, and identifying gene products that enhance tyrosine production.
Career Highlights
Throughout her career, Lauren has worked with esteemed institutions, including the University of California and Valorbec S.e.c. Her innovative research has positioned her as a key figure in her field, contributing to advancements in biochemistry and genetic engineering.
Collaborations
Some of her notable coworkers include Vincent J. J. Martin and John Eugene Dueber. Their collaborative efforts have furthered research in the area of tyrosine hydroxylase and its applications.
Conclusion
Lauren Narcross is a trailblazer in the field of biochemistry, with her innovative work on tyrosine hydroxylase variants paving the way for advancements in medical treatments. Her contributions continue to impact the scientific community and improve therapeutic options for patients.